NCT01662505 - Volasertib in Japanese Patients With Acute Myeloid Leukemia (AML) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

May 31, 2015

Study Completion Date

May 31, 2015

Conditions

Leukemia, Myeloid, Acute

Interventions

DRUG

Volasertib

Patient to receive volasertib

Trial Locations (6)

Boehringer Ingelheim Investigational Site, Chuo-ku, Tokyo

Boehringer Ingelheim Investigational Site, Isehara, Kanagawa

Boehringer Ingelheim Investigational Site, Maebashi, Gunma,

Boehringer Ingelheim Investigational Site, Nagasaki, Nagasaki

Boehringer Ingelheim Investigational Site, Nagoya-shi, Aichi

Boehringer Ingelheim Investigational Site, Yoshida-gun, Fukui